Vendor, Natick, MA
Modex Therapeutics, Inc.
UEI CDVMNSMRDTW8, CAGE 8TB78
1 award and $44,517,008 obligated between September 11, 2024 and December 23, 2025, 100% under full and open competition, against 1.0 offers on average where reported.
Sells to
Awarding agencies by dollars.
| Office of Assistant Secretary for Preparedness and Response | $44,517,008 |
Industries
NAICS on the awards, by dollars.
| Research and Development in Biotechnology (except Nanobiotechnology)NAICS 541714 | $44,517,008 |
How it wins
Awards by competition, set-aside and type.
| Full and Open Competition | 1 |
| Definitive Contract | 1 |
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| 75A50123C00056Definitive Contract, September 11, 2024, Full and Open Competition, 1 offers | Barda - Aspr / Daappo / Barda DCMAOffice of Assistant Secretary for Preparedness and Response | Advance the Development of Potent, Cross-Reactive Multispecific Antibodies for the Prep Countermeasure of Covid-19 and Seasonal and Highly PNAICS 541714, PSC AN13 | $44,517,008 |
- Places of performance
- Massachusetts
- Product and service codes
- AN13 Health R&D Services; Health Care Services; Experimental Development
- Transactions
- 5 across 1 awards